Index by author
October 01, 1996; Volume 50,Issue 4
A
Abdel-Malek, S
- You have accessDicaffeoylquinic acid inhibitors of human immunodeficiency virus integrase: inhibition of the core catalytic domain of human immunodeficiency virus integrase.W E Robinson, M Cordeiro, S Abdel-Malek, Q Jia, S A Chow, M G Reinecke and W M MitchellMolecular Pharmacology October 1996, 50 (4) 846-855;
Adams, M E
- You have accessBlock of high-threshold calcium channels by the synthetic polyamines sFTX-3.3 and FTX-3.3.T M Norris, E Moya, I S Blagbrough and M E AdamsMolecular Pharmacology October 1996, 50 (4) 939-946;
Alahari, S K
- You have accessInhibition of expression of the multidrug resistance-associated P-glycoprotein of by phosphorothioate and 5' cholesterol-conjugated phosphorothioate antisense oligonucleotides.S K Alahari, N M Dean, M H Fisher, R Delong, M Manoharan, K L Tivel and R L JulianoMolecular Pharmacology October 1996, 50 (4) 808-819;
B
Backstrom, J R
- You have accessIdentification, molecular cloning, and distribution of a short variant of the 5-hydroxytryptamine2C receptor produced by alternative splicing.H Canton, R B Emeson, E L Barker, J R Backstrom, J T Lu, M S Chang and E Sanders-BushMolecular Pharmacology October 1996, 50 (4) 799-807;
Bao, Y
- You have accessStructural determinants of substrates for the prostaglandin transporter PGT.S Itoh, R Lu, Y Bao, J D Morrow, L J Roberts and V L SchusterMolecular Pharmacology October 1996, 50 (4) 736-742; DOI: https://doi.org/10.1124/mol.50.4.736
Barker, E L
- You have accessIdentification, molecular cloning, and distribution of a short variant of the 5-hydroxytryptamine2C receptor produced by alternative splicing.H Canton, R B Emeson, E L Barker, J R Backstrom, J T Lu, M S Chang and E Sanders-BushMolecular Pharmacology October 1996, 50 (4) 799-807;
- You have accessIdentification of a single amino acid, phenylalanine 586, that is responsible for high affinity interactions of tricyclic antidepressants with the human serotonin transporter.E L Barker and R D BlakelyMolecular Pharmacology October 1996, 50 (4) 957-965;
Bass, R T
- You have accessIdentification and characterization of novel somatostatin antagonists.R T Bass, B L Buckwalter, B P Patel, M H Pausch, L A Price, J Strnad and J R HadcockMolecular Pharmacology October 1996, 50 (4) 709-715;
Beall, H D
- You have accessExpression of human NAD(P)H: quinone oxidoreductase (DT-diaphorase) in Chinese hamster ovary cells: effect on the toxicity of antitumor quinones.D L Gustafson, H D Beall, E M Bolton, D Ross and C A WaldrenMolecular Pharmacology October 1996, 50 (4) 728-735;
Berg, K A
- You have access5-hydroxytryptamine2C receptor activation inhibits 5-hydroxytryptamine1B-like receptor function via arachidonic acid metabolism.K A Berg, S Maayani and W P ClarkeMolecular Pharmacology October 1996, 50 (4) 1017-1023;
Bertrand, D
- You have accessEthanol inhibition of nicotinic acetylcholine type alpha 7 receptors involves the amino-terminal domain of the receptor.D Yu, L Zhang, J L Eiselé, D Bertrand, J P Changeux and F F WeightMolecular Pharmacology October 1996, 50 (4) 1010-1016;
Birnbaumer, M
- You have accessVasopressin V2 receptor mutants that cause X-linked nephrogenic diabetes insipidus: analysis of expression, processing, and function.A Oksche, R Schülein, C Rutz, U Liebenhoff, J Dickson, H Müller, M Birnbaumer and W RosenthalMolecular Pharmacology October 1996, 50 (4) 820-828;
Blagbrough, I S
- You have accessBlock of high-threshold calcium channels by the synthetic polyamines sFTX-3.3 and FTX-3.3.T M Norris, E Moya, I S Blagbrough and M E AdamsMolecular Pharmacology October 1996, 50 (4) 939-946;
Blakely, R D
- You have accessIdentification of a single amino acid, phenylalanine 586, that is responsible for high affinity interactions of tricyclic antidepressants with the human serotonin transporter.E L Barker and R D BlakelyMolecular Pharmacology October 1996, 50 (4) 957-965;
Bockaert, J
- You have accessCoupling of metabotropic glutamate receptors 2 and 4 to G alpha 15, G alpha 16, and chimeric G alpha q/i proteins: characterization of new antagonists.J Gomeza, S Mary, I Brabet, M L Parmentier, S Restituito, J Bockaert and J P PinMolecular Pharmacology October 1996, 50 (4) 923-930;
Bolton, E M
- You have accessExpression of human NAD(P)H: quinone oxidoreductase (DT-diaphorase) in Chinese hamster ovary cells: effect on the toxicity of antitumor quinones.D L Gustafson, H D Beall, E M Bolton, D Ross and C A WaldrenMolecular Pharmacology October 1996, 50 (4) 728-735;
Bourne, H R
- You have accessCarboxyl-terminal mutations of Gq alpha and Gs alpha that alter the fidelity of receptor activation.B R Conklin, P Herzmark, S Ishida, T A Voyno-Yasenetskaya, Y Sun, Z Farfel and H R BourneMolecular Pharmacology October 1996, 50 (4) 885-890;
Brabet, I
- You have accessCoupling of metabotropic glutamate receptors 2 and 4 to G alpha 15, G alpha 16, and chimeric G alpha q/i proteins: characterization of new antagonists.J Gomeza, S Mary, I Brabet, M L Parmentier, S Restituito, J Bockaert and J P PinMolecular Pharmacology October 1996, 50 (4) 923-930;
Bracamontes, J
- You have accessEndogenous subunits can cause ambiguities in the pharmacology of exogenous gamma-aminobutyric acidA receptors expressed in human embryonic kidney 293 cells.S Ueno, C Zorumski, J Bracamontes and J H SteinbachMolecular Pharmacology October 1996, 50 (4) 931-938;
Brust, P F
- You have accessFunctional coupling of rat group II metabotropic glutamate receptors to an omega-conotoxin GVIA-sensitive calcium channel in human embryonic kidney 293 cells.B A McCool, J P Pin, P F Brust, M M Harpold and D M LovingerMolecular Pharmacology October 1996, 50 (4) 912-922;
Buckwalter, B L
- You have accessIdentification and characterization of novel somatostatin antagonists.R T Bass, B L Buckwalter, B P Patel, M H Pausch, L A Price, J Strnad and J R HadcockMolecular Pharmacology October 1996, 50 (4) 709-715;
Burman, M
- You have accessMapping the functional domains of human recombinant phosphodiesterase 4A: structural requirements for catalytic activity and rolipram binding.S Jacobitz, M M McLaughlin, G P Livi, M Burman and T J TorphyMolecular Pharmacology October 1996, 50 (4) 891-899;
C
Canton, H
- You have accessIdentification, molecular cloning, and distribution of a short variant of the 5-hydroxytryptamine2C receptor produced by alternative splicing.H Canton, R B Emeson, E L Barker, J R Backstrom, J T Lu, M S Chang and E Sanders-BushMolecular Pharmacology October 1996, 50 (4) 799-807;
Capranico, G
- You have accessAza-bioisosteres of 9, 10-anthracenedione: a modulation of DNA sequence specificity.C Sissi, G Capranico, E Menta and M PalumboMolecular Pharmacology October 1996, 50 (4) 838-845;
Chang, M S
- You have accessIdentification, molecular cloning, and distribution of a short variant of the 5-hydroxytryptamine2C receptor produced by alternative splicing.H Canton, R B Emeson, E L Barker, J R Backstrom, J T Lu, M S Chang and E Sanders-BushMolecular Pharmacology October 1996, 50 (4) 799-807;
Changeux, J P
- You have accessEthanol inhibition of nicotinic acetylcholine type alpha 7 receptors involves the amino-terminal domain of the receptor.D Yu, L Zhang, J L Eiselé, D Bertrand, J P Changeux and F F WeightMolecular Pharmacology October 1996, 50 (4) 1010-1016;
Chao, J
- You have accessActivation of N-methyl-D-aspartate receptors by glycine: role of an aspartate residue in the M3-M4 loop of the NR1 subunit.K Williams, J Chao, K Kashiwagi, T Masuko and K IgarashiMolecular Pharmacology October 1996, 50 (4) 701-708;
Chen, J C
- You have accessMechanism of extracellular ATP-induced proliferation of vascular smooth muscle cells.S M Yu, S F Chen, Y T Lau, C M Yang and J C ChenMolecular Pharmacology October 1996, 50 (4) 1000-1009;
Chen, S F
- You have accessMechanism of extracellular ATP-induced proliferation of vascular smooth muscle cells.S M Yu, S F Chen, Y T Lau, C M Yang and J C ChenMolecular Pharmacology October 1996, 50 (4) 1000-1009;
Chow, S A
- You have accessDicaffeoylquinic acid inhibitors of human immunodeficiency virus integrase: inhibition of the core catalytic domain of human immunodeficiency virus integrase.W E Robinson, M Cordeiro, S Abdel-Malek, Q Jia, S A Chow, M G Reinecke and W M MitchellMolecular Pharmacology October 1996, 50 (4) 846-855;
Clarke, W P
- You have access5-hydroxytryptamine2C receptor activation inhibits 5-hydroxytryptamine1B-like receptor function via arachidonic acid metabolism.K A Berg, S Maayani and W P ClarkeMolecular Pharmacology October 1996, 50 (4) 1017-1023;
Cloëz-Tayarani, I
- You have access5-hydroxytryptamine-moduline, a new endogenous cerebral peptide, controls the serotonergic activity via its specific interaction with 5-hydroxytryptamine1B/1D receptors.O Massot, J C Rousselle, M P Fillion, B Grimaldi, I Cloëz-Tayarani, A Fugelli, N Prudhomme, L Seguin, B Rousseau, M Plantefol, R Hen and G FillionMolecular Pharmacology October 1996, 50 (4) 752-762;
Cohen, G M
- You have accessDNA-damaging agents induce both p53-dependent and p53-independent apoptosis in immature thymocytes.M MacFarlane, N A Jones, C Dive and G M CohenMolecular Pharmacology October 1996, 50 (4) 900-911;
Conklin, B R
- You have accessCarboxyl-terminal mutations of Gq alpha and Gs alpha that alter the fidelity of receptor activation.B R Conklin, P Herzmark, S Ishida, T A Voyno-Yasenetskaya, Y Sun, Z Farfel and H R BourneMolecular Pharmacology October 1996, 50 (4) 885-890;
Cordeiro, M
- You have accessDicaffeoylquinic acid inhibitors of human immunodeficiency virus integrase: inhibition of the core catalytic domain of human immunodeficiency virus integrase.W E Robinson, M Cordeiro, S Abdel-Malek, Q Jia, S A Chow, M G Reinecke and W M MitchellMolecular Pharmacology October 1996, 50 (4) 846-855;
D
Dean, N M
- You have accessInhibition of expression of the multidrug resistance-associated P-glycoprotein of by phosphorothioate and 5' cholesterol-conjugated phosphorothioate antisense oligonucleotides.S K Alahari, N M Dean, M H Fisher, R Delong, M Manoharan, K L Tivel and R L JulianoMolecular Pharmacology October 1996, 50 (4) 808-819;
Delong, R
- You have accessInhibition of expression of the multidrug resistance-associated P-glycoprotein of by phosphorothioate and 5' cholesterol-conjugated phosphorothioate antisense oligonucleotides.S K Alahari, N M Dean, M H Fisher, R Delong, M Manoharan, K L Tivel and R L JulianoMolecular Pharmacology October 1996, 50 (4) 808-819;
Dickson, J
- You have accessVasopressin V2 receptor mutants that cause X-linked nephrogenic diabetes insipidus: analysis of expression, processing, and function.A Oksche, R Schülein, C Rutz, U Liebenhoff, J Dickson, H Müller, M Birnbaumer and W RosenthalMolecular Pharmacology October 1996, 50 (4) 820-828;
Ding, X
- You have accessBaculovirus-mediated expression and characterization of rat CYP2A3 and human CYP2a6: role in metabolic activation of nasal toxicants.C Liu, X Zhuo, F J Gonzalez and X DingMolecular Pharmacology October 1996, 50 (4) 781-788;
Dive, C
- You have accessDNA-damaging agents induce both p53-dependent and p53-independent apoptosis in immature thymocytes.M MacFarlane, N A Jones, C Dive and G M CohenMolecular Pharmacology October 1996, 50 (4) 900-911;
Dragatsis, I
- You have accessIdentification of the critical domains of the delta-opioid receptor involved in G protein coupling using site-specific synthetic peptides.M Merkouris, I Dragatsis, G Megaritis, G Konidakis, C Zioudrou, G Milligan and Z GeorgoussiMolecular Pharmacology October 1996, 50 (4) 985-993;
E
Eiselé, J L
- You have accessEthanol inhibition of nicotinic acetylcholine type alpha 7 receptors involves the amino-terminal domain of the receptor.D Yu, L Zhang, J L Eiselé, D Bertrand, J P Changeux and F F WeightMolecular Pharmacology October 1996, 50 (4) 1010-1016;
Emeson, R B
- You have accessIdentification, molecular cloning, and distribution of a short variant of the 5-hydroxytryptamine2C receptor produced by alternative splicing.H Canton, R B Emeson, E L Barker, J R Backstrom, J T Lu, M S Chang and E Sanders-BushMolecular Pharmacology October 1996, 50 (4) 799-807;
Eusebi, F
- You have accessDesign and in vitro pharmacology of a selective gamma-aminobutyric acidC receptor antagonist.D Ragozzino, R M Woodward, Y Murata, F Eusebi, L E Overman and R MilediMolecular Pharmacology October 1996, 50 (4) 1024-1030;
Evans, C J
- You have accessVoltage-dependent inhibition of Ca2+ channels in GH3 cells by cloned mu- and delta-opioid receptors.E T Piros, P L Prather, P Y Law, C J Evans and T G HalesMolecular Pharmacology October 1996, 50 (4) 947-956;
F
Farber, J L
- You have accessThe antioxidant function of the physiological content of vitamin C.P A Glascott, M Tsyganskaya, E Gilfor, M A Zern and J L FarberMolecular Pharmacology October 1996, 50 (4) 994-999;
Farfel, Z
- You have accessCarboxyl-terminal mutations of Gq alpha and Gs alpha that alter the fidelity of receptor activation.B R Conklin, P Herzmark, S Ishida, T A Voyno-Yasenetskaya, Y Sun, Z Farfel and H R BourneMolecular Pharmacology October 1996, 50 (4) 885-890;
Fillion, G
- You have access5-hydroxytryptamine-moduline, a new endogenous cerebral peptide, controls the serotonergic activity via its specific interaction with 5-hydroxytryptamine1B/1D receptors.O Massot, J C Rousselle, M P Fillion, B Grimaldi, I Cloëz-Tayarani, A Fugelli, N Prudhomme, L Seguin, B Rousseau, M Plantefol, R Hen and G FillionMolecular Pharmacology October 1996, 50 (4) 752-762;
Fillion, M P
- You have access5-hydroxytryptamine-moduline, a new endogenous cerebral peptide, controls the serotonergic activity via its specific interaction with 5-hydroxytryptamine1B/1D receptors.O Massot, J C Rousselle, M P Fillion, B Grimaldi, I Cloëz-Tayarani, A Fugelli, N Prudhomme, L Seguin, B Rousseau, M Plantefol, R Hen and G FillionMolecular Pharmacology October 1996, 50 (4) 752-762;
Fisher, M H
- You have accessInhibition of expression of the multidrug resistance-associated P-glycoprotein of by phosphorothioate and 5' cholesterol-conjugated phosphorothioate antisense oligonucleotides.S K Alahari, N M Dean, M H Fisher, R Delong, M Manoharan, K L Tivel and R L JulianoMolecular Pharmacology October 1996, 50 (4) 808-819;
Fugelli, A
- You have access5-hydroxytryptamine-moduline, a new endogenous cerebral peptide, controls the serotonergic activity via its specific interaction with 5-hydroxytryptamine1B/1D receptors.O Massot, J C Rousselle, M P Fillion, B Grimaldi, I Cloëz-Tayarani, A Fugelli, N Prudhomme, L Seguin, B Rousseau, M Plantefol, R Hen and G FillionMolecular Pharmacology October 1996, 50 (4) 752-762;
G
Georgoussi, Z
- You have accessIdentification of the critical domains of the delta-opioid receptor involved in G protein coupling using site-specific synthetic peptides.M Merkouris, I Dragatsis, G Megaritis, G Konidakis, C Zioudrou, G Milligan and Z GeorgoussiMolecular Pharmacology October 1996, 50 (4) 985-993;
Gilfor, E
- You have accessThe antioxidant function of the physiological content of vitamin C.P A Glascott, M Tsyganskaya, E Gilfor, M A Zern and J L FarberMolecular Pharmacology October 1996, 50 (4) 994-999;
Glascott, P A
- You have accessThe antioxidant function of the physiological content of vitamin C.P A Glascott, M Tsyganskaya, E Gilfor, M A Zern and J L FarberMolecular Pharmacology October 1996, 50 (4) 994-999;
Gomeza, J
- You have accessCoupling of metabotropic glutamate receptors 2 and 4 to G alpha 15, G alpha 16, and chimeric G alpha q/i proteins: characterization of new antagonists.J Gomeza, S Mary, I Brabet, M L Parmentier, S Restituito, J Bockaert and J P PinMolecular Pharmacology October 1996, 50 (4) 923-930;
Gonzalez, F J
- You have accessBaculovirus-mediated expression and characterization of rat CYP2A3 and human CYP2a6: role in metabolic activation of nasal toxicants.C Liu, X Zhuo, F J Gonzalez and X DingMolecular Pharmacology October 1996, 50 (4) 781-788;
Grimaldi, B
- You have access5-hydroxytryptamine-moduline, a new endogenous cerebral peptide, controls the serotonergic activity via its specific interaction with 5-hydroxytryptamine1B/1D receptors.O Massot, J C Rousselle, M P Fillion, B Grimaldi, I Cloëz-Tayarani, A Fugelli, N Prudhomme, L Seguin, B Rousseau, M Plantefol, R Hen and G FillionMolecular Pharmacology October 1996, 50 (4) 752-762;
Gustafson, D L
- You have accessExpression of human NAD(P)H: quinone oxidoreductase (DT-diaphorase) in Chinese hamster ovary cells: effect on the toxicity of antitumor quinones.D L Gustafson, H D Beall, E M Bolton, D Ross and C A WaldrenMolecular Pharmacology October 1996, 50 (4) 728-735;
H
Hadcock, J R
- You have accessIdentification and characterization of novel somatostatin antagonists.R T Bass, B L Buckwalter, B P Patel, M H Pausch, L A Price, J Strnad and J R HadcockMolecular Pharmacology October 1996, 50 (4) 709-715;
- You have accessPharmacological characterization of the rat A2a adenosine receptor functionally coupled to the yeast pheromone response pathway.L A Price, J Strnad, M H Pausch and J R HadcockMolecular Pharmacology October 1996, 50 (4) 829-837;
Hales, T G
- You have accessVoltage-dependent inhibition of Ca2+ channels in GH3 cells by cloned mu- and delta-opioid receptors.E T Piros, P L Prather, P Y Law, C J Evans and T G HalesMolecular Pharmacology October 1996, 50 (4) 947-956;
Harpold, M M
- You have accessFunctional coupling of rat group II metabotropic glutamate receptors to an omega-conotoxin GVIA-sensitive calcium channel in human embryonic kidney 293 cells.B A McCool, J P Pin, P F Brust, M M Harpold and D M LovingerMolecular Pharmacology October 1996, 50 (4) 912-922;
Hen, R
- You have access5-hydroxytryptamine-moduline, a new endogenous cerebral peptide, controls the serotonergic activity via its specific interaction with 5-hydroxytryptamine1B/1D receptors.O Massot, J C Rousselle, M P Fillion, B Grimaldi, I Cloëz-Tayarani, A Fugelli, N Prudhomme, L Seguin, B Rousseau, M Plantefol, R Hen and G FillionMolecular Pharmacology October 1996, 50 (4) 752-762;
Herzmark, P
- You have accessCarboxyl-terminal mutations of Gq alpha and Gs alpha that alter the fidelity of receptor activation.B R Conklin, P Herzmark, S Ishida, T A Voyno-Yasenetskaya, Y Sun, Z Farfel and H R BourneMolecular Pharmacology October 1996, 50 (4) 885-890;
Hjorth, S A
- You have accessRadioligand-dependent discrepancy in agonist affinities enhanced by mutations in the kappa-opioid receptor.S A Hjorth, K Thirstrup and T W SchwartzMolecular Pharmacology October 1996, 50 (4) 977-984;
I
Ichikawa, A
- You have accessTwo Gs-coupled prostaglandin E receptor subtypes, EP2 and EP4, differ in desensitization and sensitivity to the metabolic inactivation of the agonist.N Nishigaki, M Negishi and A IchikawaMolecular Pharmacology October 1996, 50 (4) 1031-1037;
Igarashi, K
- You have accessActivation of N-methyl-D-aspartate receptors by glycine: role of an aspartate residue in the M3-M4 loop of the NR1 subunit.K Williams, J Chao, K Kashiwagi, T Masuko and K IgarashiMolecular Pharmacology October 1996, 50 (4) 701-708;
Ishida, S
- You have accessCarboxyl-terminal mutations of Gq alpha and Gs alpha that alter the fidelity of receptor activation.B R Conklin, P Herzmark, S Ishida, T A Voyno-Yasenetskaya, Y Sun, Z Farfel and H R BourneMolecular Pharmacology October 1996, 50 (4) 885-890;
Itoh, S
- You have accessStructural determinants of substrates for the prostaglandin transporter PGT.S Itoh, R Lu, Y Bao, J D Morrow, L J Roberts and V L SchusterMolecular Pharmacology October 1996, 50 (4) 736-742; DOI: https://doi.org/10.1124/mol.50.4.736
J
Jacobitz, S
- You have accessMapping the functional domains of human recombinant phosphodiesterase 4A: structural requirements for catalytic activity and rolipram binding.S Jacobitz, M M McLaughlin, G P Livi, M Burman and T J TorphyMolecular Pharmacology October 1996, 50 (4) 891-899;
Jakobs, K H
- You have accessm3 Muscarinic receptor-induced and Gi-mediated heterologous potentiation of phospholipase C stimulation: role of phosphoinositide synthesis.M Schmidt, C Nehls, U Rümenapp and K H JakobsMolecular Pharmacology October 1996, 50 (4) 1038-1046;
- You have accessInhibition by toxin B of inositol phosphate formation induced by G protein-coupled and tyrosine kinase receptors in N1E-115 neuroblastoma cells: involvement of Rho proteins.C Zhang, M Schmidt, C von Eichei-Streiber and K H JakobsMolecular Pharmacology October 1996, 50 (4) 864-869;
Jia, Q
- You have accessDicaffeoylquinic acid inhibitors of human immunodeficiency virus integrase: inhibition of the core catalytic domain of human immunodeficiency virus integrase.W E Robinson, M Cordeiro, S Abdel-Malek, Q Jia, S A Chow, M G Reinecke and W M MitchellMolecular Pharmacology October 1996, 50 (4) 846-855;
Jones, N A
- You have accessDNA-damaging agents induce both p53-dependent and p53-independent apoptosis in immature thymocytes.M MacFarlane, N A Jones, C Dive and G M CohenMolecular Pharmacology October 1996, 50 (4) 900-911;
Juliano, R L
- You have accessInhibition of expression of the multidrug resistance-associated P-glycoprotein of by phosphorothioate and 5' cholesterol-conjugated phosphorothioate antisense oligonucleotides.S K Alahari, N M Dean, M H Fisher, R Delong, M Manoharan, K L Tivel and R L JulianoMolecular Pharmacology October 1996, 50 (4) 808-819;
K
Kanzaki, M
- You have accessBlockade of DNA synthesis induced by platelet-derived growth factor by tranilast, an inhibitor of calcium entry, in vascular smooth muscle cells.L Nie, H Mogami, M Kanzaki, H Shibata and I KojimaMolecular Pharmacology October 1996, 50 (4) 763-769;
Kashiwagi, K
- You have accessActivation of N-methyl-D-aspartate receptors by glycine: role of an aspartate residue in the M3-M4 loop of the NR1 subunit.K Williams, J Chao, K Kashiwagi, T Masuko and K IgarashiMolecular Pharmacology October 1996, 50 (4) 701-708;
Kemp, M C
- You have accessAcemannan, a beta-(1,4)-acetylated mannan, induces nitric oxide production in macrophage cell line RAW 264.7.L Ramamoorthy, M C Kemp and I R TizardMolecular Pharmacology October 1996, 50 (4) 878-884;
Kennedy, A P
- You have accessCovalent modification of transmembrane span III of the A1 adenosine receptor with an antagonist photoaffinity probe.A P Kennedy, K C Mangum, J Linden and J N WellsMolecular Pharmacology October 1996, 50 (4) 789-798;
Kojima, I
- You have accessBlockade of DNA synthesis induced by platelet-derived growth factor by tranilast, an inhibitor of calcium entry, in vascular smooth muscle cells.L Nie, H Mogami, M Kanzaki, H Shibata and I KojimaMolecular Pharmacology October 1996, 50 (4) 763-769;
Komatsu, M
- You have accessPituitary adenylate cyclase-activating peptide, carbachol, and glucose stimulate insulin release in the absence of an increase in intracellular Ca2+.M Komatsu, T Schermerhorn, S G Straub and G W SharpMolecular Pharmacology October 1996, 50 (4) 1047-1054;
Konidakis, G
- You have accessIdentification of the critical domains of the delta-opioid receptor involved in G protein coupling using site-specific synthetic peptides.M Merkouris, I Dragatsis, G Megaritis, G Konidakis, C Zioudrou, G Milligan and Z GeorgoussiMolecular Pharmacology October 1996, 50 (4) 985-993;
L
Lau, Y T
- You have accessMechanism of extracellular ATP-induced proliferation of vascular smooth muscle cells.S M Yu, S F Chen, Y T Lau, C M Yang and J C ChenMolecular Pharmacology October 1996, 50 (4) 1000-1009;
Law, P Y
- You have accessVoltage-dependent inhibition of Ca2+ channels in GH3 cells by cloned mu- and delta-opioid receptors.E T Piros, P L Prather, P Y Law, C J Evans and T G HalesMolecular Pharmacology October 1996, 50 (4) 947-956;
Lechner, M C
- You have accessGlucocorticoid receptor-independent transcriptional induction of cytochrome P450 3A1 by metyrapone and its potentiation by glucocorticoid.M C Wright, X J Wang, M Pimenta, V Ribeiro, A J Paine and M C LechnerMolecular Pharmacology October 1996, 50 (4) 856-863;
Liebenhoff, U
- You have accessVasopressin V2 receptor mutants that cause X-linked nephrogenic diabetes insipidus: analysis of expression, processing, and function.A Oksche, R Schülein, C Rutz, U Liebenhoff, J Dickson, H Müller, M Birnbaumer and W RosenthalMolecular Pharmacology October 1996, 50 (4) 820-828;
Linden, J
- You have accessCovalent modification of transmembrane span III of the A1 adenosine receptor with an antagonist photoaffinity probe.A P Kennedy, K C Mangum, J Linden and J N WellsMolecular Pharmacology October 1996, 50 (4) 789-798;
Liu, C
- You have accessBaculovirus-mediated expression and characterization of rat CYP2A3 and human CYP2a6: role in metabolic activation of nasal toxicants.C Liu, X Zhuo, F J Gonzalez and X DingMolecular Pharmacology October 1996, 50 (4) 781-788;
Livi, G P
- You have accessMapping the functional domains of human recombinant phosphodiesterase 4A: structural requirements for catalytic activity and rolipram binding.S Jacobitz, M M McLaughlin, G P Livi, M Burman and T J TorphyMolecular Pharmacology October 1996, 50 (4) 891-899;
Lovinger, D M
- You have accessFunctional coupling of rat group II metabotropic glutamate receptors to an omega-conotoxin GVIA-sensitive calcium channel in human embryonic kidney 293 cells.B A McCool, J P Pin, P F Brust, M M Harpold and D M LovingerMolecular Pharmacology October 1996, 50 (4) 912-922;
Lu, J T
- You have accessIdentification, molecular cloning, and distribution of a short variant of the 5-hydroxytryptamine2C receptor produced by alternative splicing.H Canton, R B Emeson, E L Barker, J R Backstrom, J T Lu, M S Chang and E Sanders-BushMolecular Pharmacology October 1996, 50 (4) 799-807;
Lu, R
- You have accessStructural determinants of substrates for the prostaglandin transporter PGT.S Itoh, R Lu, Y Bao, J D Morrow, L J Roberts and V L SchusterMolecular Pharmacology October 1996, 50 (4) 736-742; DOI: https://doi.org/10.1124/mol.50.4.736
M
Maayani, S
- You have access5-hydroxytryptamine2C receptor activation inhibits 5-hydroxytryptamine1B-like receptor function via arachidonic acid metabolism.K A Berg, S Maayani and W P ClarkeMolecular Pharmacology October 1996, 50 (4) 1017-1023;
MacFarlane, M
- You have accessDNA-damaging agents induce both p53-dependent and p53-independent apoptosis in immature thymocytes.M MacFarlane, N A Jones, C Dive and G M CohenMolecular Pharmacology October 1996, 50 (4) 900-911;
Makhlouf, G M
- You have accessOpioid mu, delta, and kappa receptor-induced activation of phospholipase C-beta 3 and inhibition of adenylyl cyclase is mediated by Gi2 and G(o) in smooth muscle.K S Murthy and G M MakhloufMolecular Pharmacology October 1996, 50 (4) 870-877;
Mangum, K C
- You have accessCovalent modification of transmembrane span III of the A1 adenosine receptor with an antagonist photoaffinity probe.A P Kennedy, K C Mangum, J Linden and J N WellsMolecular Pharmacology October 1996, 50 (4) 789-798;
Manoharan, M
- You have accessInhibition of expression of the multidrug resistance-associated P-glycoprotein of by phosphorothioate and 5' cholesterol-conjugated phosphorothioate antisense oligonucleotides.S K Alahari, N M Dean, M H Fisher, R Delong, M Manoharan, K L Tivel and R L JulianoMolecular Pharmacology October 1996, 50 (4) 808-819;
Mary, S
- You have accessCoupling of metabotropic glutamate receptors 2 and 4 to G alpha 15, G alpha 16, and chimeric G alpha q/i proteins: characterization of new antagonists.J Gomeza, S Mary, I Brabet, M L Parmentier, S Restituito, J Bockaert and J P PinMolecular Pharmacology October 1996, 50 (4) 923-930;
Massot, O
- You have access5-hydroxytryptamine-moduline, a new endogenous cerebral peptide, controls the serotonergic activity via its specific interaction with 5-hydroxytryptamine1B/1D receptors.O Massot, J C Rousselle, M P Fillion, B Grimaldi, I Cloëz-Tayarani, A Fugelli, N Prudhomme, L Seguin, B Rousseau, M Plantefol, R Hen and G FillionMolecular Pharmacology October 1996, 50 (4) 752-762;
Masuko, T
- You have accessActivation of N-methyl-D-aspartate receptors by glycine: role of an aspartate residue in the M3-M4 loop of the NR1 subunit.K Williams, J Chao, K Kashiwagi, T Masuko and K IgarashiMolecular Pharmacology October 1996, 50 (4) 701-708;
McCool, B A
- You have accessFunctional coupling of rat group II metabotropic glutamate receptors to an omega-conotoxin GVIA-sensitive calcium channel in human embryonic kidney 293 cells.B A McCool, J P Pin, P F Brust, M M Harpold and D M LovingerMolecular Pharmacology October 1996, 50 (4) 912-922;
McLaughlin, M M
- You have accessMapping the functional domains of human recombinant phosphodiesterase 4A: structural requirements for catalytic activity and rolipram binding.S Jacobitz, M M McLaughlin, G P Livi, M Burman and T J TorphyMolecular Pharmacology October 1996, 50 (4) 891-899;
Megaritis, G
- You have accessIdentification of the critical domains of the delta-opioid receptor involved in G protein coupling using site-specific synthetic peptides.M Merkouris, I Dragatsis, G Megaritis, G Konidakis, C Zioudrou, G Milligan and Z GeorgoussiMolecular Pharmacology October 1996, 50 (4) 985-993;
Menta, E
- You have accessAza-bioisosteres of 9, 10-anthracenedione: a modulation of DNA sequence specificity.C Sissi, G Capranico, E Menta and M PalumboMolecular Pharmacology October 1996, 50 (4) 838-845;
Merkouris, M
- You have accessIdentification of the critical domains of the delta-opioid receptor involved in G protein coupling using site-specific synthetic peptides.M Merkouris, I Dragatsis, G Megaritis, G Konidakis, C Zioudrou, G Milligan and Z GeorgoussiMolecular Pharmacology October 1996, 50 (4) 985-993;
Miledi, R
- You have accessDesign and in vitro pharmacology of a selective gamma-aminobutyric acidC receptor antagonist.D Ragozzino, R M Woodward, Y Murata, F Eusebi, L E Overman and R MilediMolecular Pharmacology October 1996, 50 (4) 1024-1030;
Milligan, G
- You have accessIdentification of the critical domains of the delta-opioid receptor involved in G protein coupling using site-specific synthetic peptides.M Merkouris, I Dragatsis, G Megaritis, G Konidakis, C Zioudrou, G Milligan and Z GeorgoussiMolecular Pharmacology October 1996, 50 (4) 985-993;
Mitchell, W M
- You have accessDicaffeoylquinic acid inhibitors of human immunodeficiency virus integrase: inhibition of the core catalytic domain of human immunodeficiency virus integrase.W E Robinson, M Cordeiro, S Abdel-Malek, Q Jia, S A Chow, M G Reinecke and W M MitchellMolecular Pharmacology October 1996, 50 (4) 846-855;
Mogami, H
- You have accessBlockade of DNA synthesis induced by platelet-derived growth factor by tranilast, an inhibitor of calcium entry, in vascular smooth muscle cells.L Nie, H Mogami, M Kanzaki, H Shibata and I KojimaMolecular Pharmacology October 1996, 50 (4) 763-769;
Morrow, J D
- You have accessStructural determinants of substrates for the prostaglandin transporter PGT.S Itoh, R Lu, Y Bao, J D Morrow, L J Roberts and V L SchusterMolecular Pharmacology October 1996, 50 (4) 736-742; DOI: https://doi.org/10.1124/mol.50.4.736
Moya, E
- You have accessBlock of high-threshold calcium channels by the synthetic polyamines sFTX-3.3 and FTX-3.3.T M Norris, E Moya, I S Blagbrough and M E AdamsMolecular Pharmacology October 1996, 50 (4) 939-946;
Müller, H
- You have accessVasopressin V2 receptor mutants that cause X-linked nephrogenic diabetes insipidus: analysis of expression, processing, and function.A Oksche, R Schülein, C Rutz, U Liebenhoff, J Dickson, H Müller, M Birnbaumer and W RosenthalMolecular Pharmacology October 1996, 50 (4) 820-828;
Murata, Y
- You have accessDesign and in vitro pharmacology of a selective gamma-aminobutyric acidC receptor antagonist.D Ragozzino, R M Woodward, Y Murata, F Eusebi, L E Overman and R MilediMolecular Pharmacology October 1996, 50 (4) 1024-1030;
Murphy, T J
- You have accessEnhanced angiotensin receptor type 1 mRNA degradation and induction of polyribosomal mRNA binding proteins by angiotensin II in vascular smooth muscle cells.G Nickenig and T J MurphyMolecular Pharmacology October 1996, 50 (4) 743-751;
Murthy, K S
- You have accessOpioid mu, delta, and kappa receptor-induced activation of phospholipase C-beta 3 and inhibition of adenylyl cyclase is mediated by Gi2 and G(o) in smooth muscle.K S Murthy and G M MakhloufMolecular Pharmacology October 1996, 50 (4) 870-877;
N
Negishi, M
- You have accessTwo Gs-coupled prostaglandin E receptor subtypes, EP2 and EP4, differ in desensitization and sensitivity to the metabolic inactivation of the agonist.N Nishigaki, M Negishi and A IchikawaMolecular Pharmacology October 1996, 50 (4) 1031-1037;
Nehls, C
- You have accessm3 Muscarinic receptor-induced and Gi-mediated heterologous potentiation of phospholipase C stimulation: role of phosphoinositide synthesis.M Schmidt, C Nehls, U Rümenapp and K H JakobsMolecular Pharmacology October 1996, 50 (4) 1038-1046;
Neve, K A
- You have accessSensitization of endogenous and recombinant adenylate cyclase by activation of D2 dopamine receptors.V J Watts and K A NeveMolecular Pharmacology October 1996, 50 (4) 966-976;
Nickenig, G
- You have accessEnhanced angiotensin receptor type 1 mRNA degradation and induction of polyribosomal mRNA binding proteins by angiotensin II in vascular smooth muscle cells.G Nickenig and T J MurphyMolecular Pharmacology October 1996, 50 (4) 743-751;
Nie, L
- You have accessBlockade of DNA synthesis induced by platelet-derived growth factor by tranilast, an inhibitor of calcium entry, in vascular smooth muscle cells.L Nie, H Mogami, M Kanzaki, H Shibata and I KojimaMolecular Pharmacology October 1996, 50 (4) 763-769;
Nishigaki, N
- You have accessTwo Gs-coupled prostaglandin E receptor subtypes, EP2 and EP4, differ in desensitization and sensitivity to the metabolic inactivation of the agonist.N Nishigaki, M Negishi and A IchikawaMolecular Pharmacology October 1996, 50 (4) 1031-1037;
Norris, T M
- You have accessBlock of high-threshold calcium channels by the synthetic polyamines sFTX-3.3 and FTX-3.3.T M Norris, E Moya, I S Blagbrough and M E AdamsMolecular Pharmacology October 1996, 50 (4) 939-946;
O
Oksche, A
- You have accessVasopressin V2 receptor mutants that cause X-linked nephrogenic diabetes insipidus: analysis of expression, processing, and function.A Oksche, R Schülein, C Rutz, U Liebenhoff, J Dickson, H Müller, M Birnbaumer and W RosenthalMolecular Pharmacology October 1996, 50 (4) 820-828;
Oswald, R E
- You have accessLigand-binding characteristics and related structural features of the expressed goldfish kainate receptors: identification of a conserved disulfide bond and three residues important for ligand binding.Z G Wo and R E OswaldMolecular Pharmacology October 1996, 50 (4) 770-780;
Overman, L E
- You have accessDesign and in vitro pharmacology of a selective gamma-aminobutyric acidC receptor antagonist.D Ragozzino, R M Woodward, Y Murata, F Eusebi, L E Overman and R MilediMolecular Pharmacology October 1996, 50 (4) 1024-1030;
P
Paine, A J
- You have accessGlucocorticoid receptor-independent transcriptional induction of cytochrome P450 3A1 by metyrapone and its potentiation by glucocorticoid.M C Wright, X J Wang, M Pimenta, V Ribeiro, A J Paine and M C LechnerMolecular Pharmacology October 1996, 50 (4) 856-863;
Palumbo, M
- You have accessAza-bioisosteres of 9, 10-anthracenedione: a modulation of DNA sequence specificity.C Sissi, G Capranico, E Menta and M PalumboMolecular Pharmacology October 1996, 50 (4) 838-845;
Parmentier, M L
- You have accessCoupling of metabotropic glutamate receptors 2 and 4 to G alpha 15, G alpha 16, and chimeric G alpha q/i proteins: characterization of new antagonists.J Gomeza, S Mary, I Brabet, M L Parmentier, S Restituito, J Bockaert and J P PinMolecular Pharmacology October 1996, 50 (4) 923-930;
Patel, B P
- You have accessIdentification and characterization of novel somatostatin antagonists.R T Bass, B L Buckwalter, B P Patel, M H Pausch, L A Price, J Strnad and J R HadcockMolecular Pharmacology October 1996, 50 (4) 709-715;
Pausch, M H
- You have accessIdentification and characterization of novel somatostatin antagonists.R T Bass, B L Buckwalter, B P Patel, M H Pausch, L A Price, J Strnad and J R HadcockMolecular Pharmacology October 1996, 50 (4) 709-715;
- You have accessPharmacological characterization of the rat A2a adenosine receptor functionally coupled to the yeast pheromone response pathway.L A Price, J Strnad, M H Pausch and J R HadcockMolecular Pharmacology October 1996, 50 (4) 829-837;
Pimenta, M
- You have accessGlucocorticoid receptor-independent transcriptional induction of cytochrome P450 3A1 by metyrapone and its potentiation by glucocorticoid.M C Wright, X J Wang, M Pimenta, V Ribeiro, A J Paine and M C LechnerMolecular Pharmacology October 1996, 50 (4) 856-863;
Pin, J P
- You have accessFunctional coupling of rat group II metabotropic glutamate receptors to an omega-conotoxin GVIA-sensitive calcium channel in human embryonic kidney 293 cells.B A McCool, J P Pin, P F Brust, M M Harpold and D M LovingerMolecular Pharmacology October 1996, 50 (4) 912-922;
- You have accessCoupling of metabotropic glutamate receptors 2 and 4 to G alpha 15, G alpha 16, and chimeric G alpha q/i proteins: characterization of new antagonists.J Gomeza, S Mary, I Brabet, M L Parmentier, S Restituito, J Bockaert and J P PinMolecular Pharmacology October 1996, 50 (4) 923-930;
Piros, E T
- You have accessVoltage-dependent inhibition of Ca2+ channels in GH3 cells by cloned mu- and delta-opioid receptors.E T Piros, P L Prather, P Y Law, C J Evans and T G HalesMolecular Pharmacology October 1996, 50 (4) 947-956;
Plantefol, M
- You have access5-hydroxytryptamine-moduline, a new endogenous cerebral peptide, controls the serotonergic activity via its specific interaction with 5-hydroxytryptamine1B/1D receptors.O Massot, J C Rousselle, M P Fillion, B Grimaldi, I Cloëz-Tayarani, A Fugelli, N Prudhomme, L Seguin, B Rousseau, M Plantefol, R Hen and G FillionMolecular Pharmacology October 1996, 50 (4) 752-762;
Prather, P L
- You have accessVoltage-dependent inhibition of Ca2+ channels in GH3 cells by cloned mu- and delta-opioid receptors.E T Piros, P L Prather, P Y Law, C J Evans and T G HalesMolecular Pharmacology October 1996, 50 (4) 947-956;
Price, L A
- You have accessIdentification and characterization of novel somatostatin antagonists.R T Bass, B L Buckwalter, B P Patel, M H Pausch, L A Price, J Strnad and J R HadcockMolecular Pharmacology October 1996, 50 (4) 709-715;
- You have accessPharmacological characterization of the rat A2a adenosine receptor functionally coupled to the yeast pheromone response pathway.L A Price, J Strnad, M H Pausch and J R HadcockMolecular Pharmacology October 1996, 50 (4) 829-837;
Prudhomme, N
- You have access5-hydroxytryptamine-moduline, a new endogenous cerebral peptide, controls the serotonergic activity via its specific interaction with 5-hydroxytryptamine1B/1D receptors.O Massot, J C Rousselle, M P Fillion, B Grimaldi, I Cloëz-Tayarani, A Fugelli, N Prudhomme, L Seguin, B Rousseau, M Plantefol, R Hen and G FillionMolecular Pharmacology October 1996, 50 (4) 752-762;
R
Ragozzino, D
- You have accessDesign and in vitro pharmacology of a selective gamma-aminobutyric acidC receptor antagonist.D Ragozzino, R M Woodward, Y Murata, F Eusebi, L E Overman and R MilediMolecular Pharmacology October 1996, 50 (4) 1024-1030;
Ramamoorthy, L
- You have accessAcemannan, a beta-(1,4)-acetylated mannan, induces nitric oxide production in macrophage cell line RAW 264.7.L Ramamoorthy, M C Kemp and I R TizardMolecular Pharmacology October 1996, 50 (4) 878-884;
Reinecke, M G
- You have accessDicaffeoylquinic acid inhibitors of human immunodeficiency virus integrase: inhibition of the core catalytic domain of human immunodeficiency virus integrase.W E Robinson, M Cordeiro, S Abdel-Malek, Q Jia, S A Chow, M G Reinecke and W M MitchellMolecular Pharmacology October 1996, 50 (4) 846-855;
Restituito, S
- You have accessCoupling of metabotropic glutamate receptors 2 and 4 to G alpha 15, G alpha 16, and chimeric G alpha q/i proteins: characterization of new antagonists.J Gomeza, S Mary, I Brabet, M L Parmentier, S Restituito, J Bockaert and J P PinMolecular Pharmacology October 1996, 50 (4) 923-930;
Ribeiro, V
- You have accessGlucocorticoid receptor-independent transcriptional induction of cytochrome P450 3A1 by metyrapone and its potentiation by glucocorticoid.M C Wright, X J Wang, M Pimenta, V Ribeiro, A J Paine and M C LechnerMolecular Pharmacology October 1996, 50 (4) 856-863;
Roberts, L J
- You have accessStructural determinants of substrates for the prostaglandin transporter PGT.S Itoh, R Lu, Y Bao, J D Morrow, L J Roberts and V L SchusterMolecular Pharmacology October 1996, 50 (4) 736-742; DOI: https://doi.org/10.1124/mol.50.4.736
Robinson, W E
- You have accessDicaffeoylquinic acid inhibitors of human immunodeficiency virus integrase: inhibition of the core catalytic domain of human immunodeficiency virus integrase.W E Robinson, M Cordeiro, S Abdel-Malek, Q Jia, S A Chow, M G Reinecke and W M MitchellMolecular Pharmacology October 1996, 50 (4) 846-855;
Rosenthal, W
- You have accessVasopressin V2 receptor mutants that cause X-linked nephrogenic diabetes insipidus: analysis of expression, processing, and function.A Oksche, R Schülein, C Rutz, U Liebenhoff, J Dickson, H Müller, M Birnbaumer and W RosenthalMolecular Pharmacology October 1996, 50 (4) 820-828;
Ross, D
- You have accessExpression of human NAD(P)H: quinone oxidoreductase (DT-diaphorase) in Chinese hamster ovary cells: effect on the toxicity of antitumor quinones.D L Gustafson, H D Beall, E M Bolton, D Ross and C A WaldrenMolecular Pharmacology October 1996, 50 (4) 728-735;
Rousseau, B
- You have access5-hydroxytryptamine-moduline, a new endogenous cerebral peptide, controls the serotonergic activity via its specific interaction with 5-hydroxytryptamine1B/1D receptors.O Massot, J C Rousselle, M P Fillion, B Grimaldi, I Cloëz-Tayarani, A Fugelli, N Prudhomme, L Seguin, B Rousseau, M Plantefol, R Hen and G FillionMolecular Pharmacology October 1996, 50 (4) 752-762;
Rousselle, J C
- You have access5-hydroxytryptamine-moduline, a new endogenous cerebral peptide, controls the serotonergic activity via its specific interaction with 5-hydroxytryptamine1B/1D receptors.O Massot, J C Rousselle, M P Fillion, B Grimaldi, I Cloëz-Tayarani, A Fugelli, N Prudhomme, L Seguin, B Rousseau, M Plantefol, R Hen and G FillionMolecular Pharmacology October 1996, 50 (4) 752-762;
Rümenapp, U
- You have accessm3 Muscarinic receptor-induced and Gi-mediated heterologous potentiation of phospholipase C stimulation: role of phosphoinositide synthesis.M Schmidt, C Nehls, U Rümenapp and K H JakobsMolecular Pharmacology October 1996, 50 (4) 1038-1046;
Rutz, C
- You have accessVasopressin V2 receptor mutants that cause X-linked nephrogenic diabetes insipidus: analysis of expression, processing, and function.A Oksche, R Schülein, C Rutz, U Liebenhoff, J Dickson, H Müller, M Birnbaumer and W RosenthalMolecular Pharmacology October 1996, 50 (4) 820-828;
S
Sanders-Bush, E
- You have accessIdentification, molecular cloning, and distribution of a short variant of the 5-hydroxytryptamine2C receptor produced by alternative splicing.H Canton, R B Emeson, E L Barker, J R Backstrom, J T Lu, M S Chang and E Sanders-BushMolecular Pharmacology October 1996, 50 (4) 799-807;
Schermerhorn, T
- You have accessPituitary adenylate cyclase-activating peptide, carbachol, and glucose stimulate insulin release in the absence of an increase in intracellular Ca2+.M Komatsu, T Schermerhorn, S G Straub and G W SharpMolecular Pharmacology October 1996, 50 (4) 1047-1054;
Schmidt, M
- You have accessm3 Muscarinic receptor-induced and Gi-mediated heterologous potentiation of phospholipase C stimulation: role of phosphoinositide synthesis.M Schmidt, C Nehls, U Rümenapp and K H JakobsMolecular Pharmacology October 1996, 50 (4) 1038-1046;
- You have accessInhibition by toxin B of inositol phosphate formation induced by G protein-coupled and tyrosine kinase receptors in N1E-115 neuroblastoma cells: involvement of Rho proteins.C Zhang, M Schmidt, C von Eichei-Streiber and K H JakobsMolecular Pharmacology October 1996, 50 (4) 864-869;
Schonbrunn, A
- You have accessAgonist binding and protein kinase C activation stimulate phosphorylation of the gastrin-releasing peptide receptor at distinct sites.B Y Williams, Y Wang and A SchonbrunnMolecular Pharmacology October 1996, 50 (4) 716-727;
Schülein, R
- You have accessVasopressin V2 receptor mutants that cause X-linked nephrogenic diabetes insipidus: analysis of expression, processing, and function.A Oksche, R Schülein, C Rutz, U Liebenhoff, J Dickson, H Müller, M Birnbaumer and W RosenthalMolecular Pharmacology October 1996, 50 (4) 820-828;
Schuster, V L
- You have accessStructural determinants of substrates for the prostaglandin transporter PGT.S Itoh, R Lu, Y Bao, J D Morrow, L J Roberts and V L SchusterMolecular Pharmacology October 1996, 50 (4) 736-742; DOI: https://doi.org/10.1124/mol.50.4.736
Schwartz, T W
- You have accessRadioligand-dependent discrepancy in agonist affinities enhanced by mutations in the kappa-opioid receptor.S A Hjorth, K Thirstrup and T W SchwartzMolecular Pharmacology October 1996, 50 (4) 977-984;
Seguin, L
- You have access5-hydroxytryptamine-moduline, a new endogenous cerebral peptide, controls the serotonergic activity via its specific interaction with 5-hydroxytryptamine1B/1D receptors.O Massot, J C Rousselle, M P Fillion, B Grimaldi, I Cloëz-Tayarani, A Fugelli, N Prudhomme, L Seguin, B Rousseau, M Plantefol, R Hen and G FillionMolecular Pharmacology October 1996, 50 (4) 752-762;
Sharp, G W
- You have accessPituitary adenylate cyclase-activating peptide, carbachol, and glucose stimulate insulin release in the absence of an increase in intracellular Ca2+.M Komatsu, T Schermerhorn, S G Straub and G W SharpMolecular Pharmacology October 1996, 50 (4) 1047-1054;
Shibata, H
- You have accessBlockade of DNA synthesis induced by platelet-derived growth factor by tranilast, an inhibitor of calcium entry, in vascular smooth muscle cells.L Nie, H Mogami, M Kanzaki, H Shibata and I KojimaMolecular Pharmacology October 1996, 50 (4) 763-769;
Sissi, C
- You have accessAza-bioisosteres of 9, 10-anthracenedione: a modulation of DNA sequence specificity.C Sissi, G Capranico, E Menta and M PalumboMolecular Pharmacology October 1996, 50 (4) 838-845;
Steinbach, J H
- You have accessEndogenous subunits can cause ambiguities in the pharmacology of exogenous gamma-aminobutyric acidA receptors expressed in human embryonic kidney 293 cells.S Ueno, C Zorumski, J Bracamontes and J H SteinbachMolecular Pharmacology October 1996, 50 (4) 931-938;
Straub, S G
- You have accessPituitary adenylate cyclase-activating peptide, carbachol, and glucose stimulate insulin release in the absence of an increase in intracellular Ca2+.M Komatsu, T Schermerhorn, S G Straub and G W SharpMolecular Pharmacology October 1996, 50 (4) 1047-1054;
Strnad, J
- You have accessIdentification and characterization of novel somatostatin antagonists.R T Bass, B L Buckwalter, B P Patel, M H Pausch, L A Price, J Strnad and J R HadcockMolecular Pharmacology October 1996, 50 (4) 709-715;
- You have accessPharmacological characterization of the rat A2a adenosine receptor functionally coupled to the yeast pheromone response pathway.L A Price, J Strnad, M H Pausch and J R HadcockMolecular Pharmacology October 1996, 50 (4) 829-837;
Sun, Y
- You have accessCarboxyl-terminal mutations of Gq alpha and Gs alpha that alter the fidelity of receptor activation.B R Conklin, P Herzmark, S Ishida, T A Voyno-Yasenetskaya, Y Sun, Z Farfel and H R BourneMolecular Pharmacology October 1996, 50 (4) 885-890;
T
Thirstrup, K
- You have accessRadioligand-dependent discrepancy in agonist affinities enhanced by mutations in the kappa-opioid receptor.S A Hjorth, K Thirstrup and T W SchwartzMolecular Pharmacology October 1996, 50 (4) 977-984;
Tivel, K L
- You have accessInhibition of expression of the multidrug resistance-associated P-glycoprotein of by phosphorothioate and 5' cholesterol-conjugated phosphorothioate antisense oligonucleotides.S K Alahari, N M Dean, M H Fisher, R Delong, M Manoharan, K L Tivel and R L JulianoMolecular Pharmacology October 1996, 50 (4) 808-819;
Tizard, I R
- You have accessAcemannan, a beta-(1,4)-acetylated mannan, induces nitric oxide production in macrophage cell line RAW 264.7.L Ramamoorthy, M C Kemp and I R TizardMolecular Pharmacology October 1996, 50 (4) 878-884;
Torphy, T J
- You have accessMapping the functional domains of human recombinant phosphodiesterase 4A: structural requirements for catalytic activity and rolipram binding.S Jacobitz, M M McLaughlin, G P Livi, M Burman and T J TorphyMolecular Pharmacology October 1996, 50 (4) 891-899;
Tsyganskaya, M
- You have accessThe antioxidant function of the physiological content of vitamin C.P A Glascott, M Tsyganskaya, E Gilfor, M A Zern and J L FarberMolecular Pharmacology October 1996, 50 (4) 994-999;
U
Ueno, S
- You have accessEndogenous subunits can cause ambiguities in the pharmacology of exogenous gamma-aminobutyric acidA receptors expressed in human embryonic kidney 293 cells.S Ueno, C Zorumski, J Bracamontes and J H SteinbachMolecular Pharmacology October 1996, 50 (4) 931-938;
V
von Eichei-Streiber, C
- You have accessInhibition by toxin B of inositol phosphate formation induced by G protein-coupled and tyrosine kinase receptors in N1E-115 neuroblastoma cells: involvement of Rho proteins.C Zhang, M Schmidt, C von Eichei-Streiber and K H JakobsMolecular Pharmacology October 1996, 50 (4) 864-869;
Voyno-Yasenetskaya, T A
- You have accessCarboxyl-terminal mutations of Gq alpha and Gs alpha that alter the fidelity of receptor activation.B R Conklin, P Herzmark, S Ishida, T A Voyno-Yasenetskaya, Y Sun, Z Farfel and H R BourneMolecular Pharmacology October 1996, 50 (4) 885-890;
W
Waldren, C A
- You have accessExpression of human NAD(P)H: quinone oxidoreductase (DT-diaphorase) in Chinese hamster ovary cells: effect on the toxicity of antitumor quinones.D L Gustafson, H D Beall, E M Bolton, D Ross and C A WaldrenMolecular Pharmacology October 1996, 50 (4) 728-735;
Wang, X J
- You have accessGlucocorticoid receptor-independent transcriptional induction of cytochrome P450 3A1 by metyrapone and its potentiation by glucocorticoid.M C Wright, X J Wang, M Pimenta, V Ribeiro, A J Paine and M C LechnerMolecular Pharmacology October 1996, 50 (4) 856-863;
Wang, Y
- You have accessAgonist binding and protein kinase C activation stimulate phosphorylation of the gastrin-releasing peptide receptor at distinct sites.B Y Williams, Y Wang and A SchonbrunnMolecular Pharmacology October 1996, 50 (4) 716-727;
Watts, V J
- You have accessSensitization of endogenous and recombinant adenylate cyclase by activation of D2 dopamine receptors.V J Watts and K A NeveMolecular Pharmacology October 1996, 50 (4) 966-976;
Weight, F F
- You have accessEthanol inhibition of nicotinic acetylcholine type alpha 7 receptors involves the amino-terminal domain of the receptor.D Yu, L Zhang, J L Eiselé, D Bertrand, J P Changeux and F F WeightMolecular Pharmacology October 1996, 50 (4) 1010-1016;
Wells, J N
- You have accessCovalent modification of transmembrane span III of the A1 adenosine receptor with an antagonist photoaffinity probe.A P Kennedy, K C Mangum, J Linden and J N WellsMolecular Pharmacology October 1996, 50 (4) 789-798;
Williams, B Y
- You have accessAgonist binding and protein kinase C activation stimulate phosphorylation of the gastrin-releasing peptide receptor at distinct sites.B Y Williams, Y Wang and A SchonbrunnMolecular Pharmacology October 1996, 50 (4) 716-727;
Williams, K
- You have accessActivation of N-methyl-D-aspartate receptors by glycine: role of an aspartate residue in the M3-M4 loop of the NR1 subunit.K Williams, J Chao, K Kashiwagi, T Masuko and K IgarashiMolecular Pharmacology October 1996, 50 (4) 701-708;
Wo, Z G
- You have accessLigand-binding characteristics and related structural features of the expressed goldfish kainate receptors: identification of a conserved disulfide bond and three residues important for ligand binding.Z G Wo and R E OswaldMolecular Pharmacology October 1996, 50 (4) 770-780;
Woodward, R M
- You have accessDesign and in vitro pharmacology of a selective gamma-aminobutyric acidC receptor antagonist.D Ragozzino, R M Woodward, Y Murata, F Eusebi, L E Overman and R MilediMolecular Pharmacology October 1996, 50 (4) 1024-1030;
Wright, M C
- You have accessGlucocorticoid receptor-independent transcriptional induction of cytochrome P450 3A1 by metyrapone and its potentiation by glucocorticoid.M C Wright, X J Wang, M Pimenta, V Ribeiro, A J Paine and M C LechnerMolecular Pharmacology October 1996, 50 (4) 856-863;
Y
Yang, C M
- You have accessMechanism of extracellular ATP-induced proliferation of vascular smooth muscle cells.S M Yu, S F Chen, Y T Lau, C M Yang and J C ChenMolecular Pharmacology October 1996, 50 (4) 1000-1009;
Yu, D
- You have accessEthanol inhibition of nicotinic acetylcholine type alpha 7 receptors involves the amino-terminal domain of the receptor.D Yu, L Zhang, J L Eiselé, D Bertrand, J P Changeux and F F WeightMolecular Pharmacology October 1996, 50 (4) 1010-1016;
Yu, S M
- You have accessMechanism of extracellular ATP-induced proliferation of vascular smooth muscle cells.S M Yu, S F Chen, Y T Lau, C M Yang and J C ChenMolecular Pharmacology October 1996, 50 (4) 1000-1009;
Z
Zern, M A
- You have accessThe antioxidant function of the physiological content of vitamin C.P A Glascott, M Tsyganskaya, E Gilfor, M A Zern and J L FarberMolecular Pharmacology October 1996, 50 (4) 994-999;
Zhang, C
- You have accessInhibition by toxin B of inositol phosphate formation induced by G protein-coupled and tyrosine kinase receptors in N1E-115 neuroblastoma cells: involvement of Rho proteins.C Zhang, M Schmidt, C von Eichei-Streiber and K H JakobsMolecular Pharmacology October 1996, 50 (4) 864-869;
Zhang, L
- You have accessEthanol inhibition of nicotinic acetylcholine type alpha 7 receptors involves the amino-terminal domain of the receptor.D Yu, L Zhang, J L Eiselé, D Bertrand, J P Changeux and F F WeightMolecular Pharmacology October 1996, 50 (4) 1010-1016;
Zhuo, X
- You have accessBaculovirus-mediated expression and characterization of rat CYP2A3 and human CYP2a6: role in metabolic activation of nasal toxicants.C Liu, X Zhuo, F J Gonzalez and X DingMolecular Pharmacology October 1996, 50 (4) 781-788;
Zioudrou, C
- You have accessIdentification of the critical domains of the delta-opioid receptor involved in G protein coupling using site-specific synthetic peptides.M Merkouris, I Dragatsis, G Megaritis, G Konidakis, C Zioudrou, G Milligan and Z GeorgoussiMolecular Pharmacology October 1996, 50 (4) 985-993;
Zorumski, C
- You have accessEndogenous subunits can cause ambiguities in the pharmacology of exogenous gamma-aminobutyric acidA receptors expressed in human embryonic kidney 293 cells.S Ueno, C Zorumski, J Bracamontes and J H SteinbachMolecular Pharmacology October 1996, 50 (4) 931-938;
In this issue

Advertisement